Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer
NCT00402025
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL:
Talimogene Laherparepvec
Sponsor
BioVex Limited